Stay updated on Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial
Sign up to get notified when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.

Latest updates to the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page
- Check5 days agoChange DetectedThe study history now shows a new revision entry (v3.5.5) as the latest update, replacing the previous revision (v3.5.4) in the list.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe record history now shows a new latest revision entry labeled v3.5.4. This replaces the previous v3.5.3 and indicates a minor update to the page’s revision history for this study.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.5.3 is now displayed, replacing the previous v3.5.2. This indicates a new site release of ClinicalTrials.gov.SummaryDifference0.1%

- Check55 days agoChange Detected- Revision history now shows an added v3.5.2 entry and a removed v3.5.0 entry. - The page content and layout remain unchanged.SummaryDifference0.1%

- Check84 days agoChange DetectedNew record history entry for Study Status was added on 2026-03-11 (version 35, Revision: v3.5.0). The earlier revision 3.4.3 was removed on 2026-03-05.SummaryDifference0.3%

- Check91 days agoChange DetectedNew Study Status entry added to the record history. The page revision updated to v3.4.3 and the previous v3.4.2 revision was removed.SummaryDifference0.3%

Stay in the know with updates to Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.